Guangdong Zhongsheng Pharmaceutical Co., Ltd. (SHE:002317)
China · Delayed Price · Currency is CNY 25.49
+2.32 (10.01%)
Oct 9, 2026, 3:04 PM CST
SHE:002317 Market Cap
SHE:002317 has a market cap or net worth of 21.66 billion as of October 9, 2026. It is the 4,960th most valuable company in the world and the 790th biggest in China. Its market cap has increased by 48.48% in one year.
Market Cap
21.66B
Enterprise Value
20.36B
Revenue
2.22B
Global Rank
Country Rank
#790 China
PE Ratio
107.08
ChartMarket Cap Chart
Since December 11, 2009, SHE:002317's market cap has increased from 7.22B to 21.66B, an increase of 200.27%. That is a compound annual growth rate of 6.75%.
| Date | Market Cap | % Change |
|---|---|---|
| Oct 9, 2026 | 21.66B | 34.30% |
| Dec 31, 2025 | 16.13B | 56.94% |
| Dec 31, 2024 | 10.28B | -24.46% |
| Dec 29, 2023 | 13.61B | -37.64% |
| Dec 30, 2022 | 21.82B | 126.34% |
| Dec 31, 2021 | 9.64B | 8.90% |
| Dec 31, 2020 | Upgrade Pro | Upgrade Pro |
| Dec 31, 2019 | Upgrade Pro | Upgrade Pro |
| Dec 28, 2018 | Upgrade Pro | Upgrade Pro |
| Dec 29, 2017 | Upgrade Pro | Upgrade Pro |
| Dec 30, 2016 | Upgrade Pro | Upgrade Pro |
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Related Stocks
| Company | Market Cap |
|---|---|
| Hubei Jumpcan Pharmaceutical | 24.61B |
| Tianjin Pharmaceutical Da Ren Tang Group Corporation | 23.83B |
| Livzon Pharmaceutical Group | 23.61B |
| Walvax Biotechnology | 23.59B |
| Jiangsu Nhwa Pharmaceutical Co., LTD | 22.08B |
| Tasly Pharmaceutical Group | 21.21B |
| Hybio Pharmaceutical | 20.94B |
| Jilin Aodong Pharmaceutical Group | 20.55B |